GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Meta] the Apotheke rule is doing its job and people should stop complaining — 68 comments in the full submission. View in context.
2.3k
c/glp1eu·submitted 1 year ago by u/meera_oyelaran

[Meta] the Apotheke rule is doing its job and people should stop complaining

Pricingbranch of 8 comments

the Apotheke rule is doing its job and people should stop complaining — posting the reasoning in public because a policy you cannot inspect is just a preference. Published reimbursement criteria exist in most member states and are usually available in the national language. They are the authoritative answer to…

Read the full submission and all 68 comments →

This branch

8 comments, started 1 year ago
u/nadia_nascimento61 points·1 year ago·edited

Cross-border prescription recognition exists under EU rules but is conditional and narrower than commonly assumed, with requirements about the prescription’s form and content.

replysharereportpermalink
u/adaeze_cabrera15 points·1 year ago·edited

Disagree. That is one member state’s reimbursement rule and it does not generalise across the union.

replysharereportpermalink
u/meera_oyelaranOP0 points·1 year ago

That shortage notice was national and does not apply where the question is coming from.

replysharereportpermalink
u/meera_oyelaranOP1 point·1 year ago

Correction: that is the authorisation position, and the question was about reimbursement. Different bodies, different answers.

replysharereportpermalink
u/bilal_adebayo21 points·1 year ago

pharmacy margins are regulated differently in each country

replysharereportpermalink
u/sena_teixeira15 points·1 year ago

Small fix — those two prices are for different pack sizes, which accounts for most of the gap.

replysharereportpermalink
u/sten_palacios26 points·1 year ago

pharmacy margins are regulated differently in each country

bilal_adebayo is right about cross-border recognition being narrower than the summaries suggest.

replysharereportpermalink
u/dario_bakken14 points·1 year ago

Agreed — authorisation is European, reimbursement is national, and almost every confused thread here misses that split.

replysharereportpermalink

← back to the whole thread

About c/glp1eu

European access, country by country: prescription routes, reimbursement reality, pharmacy stock, EMA notices and the fact that "EU rules" is usually a national question wearing a European hat.

32kmembers
62submissions
Apr 2024created
submissions / month, last year
Sponsored

Janoshik Analytical

Independent HPLC and mass spec. The number you get is the number they found.

janoshik.com
Sponsored

GL Biochem (Shanghai)

Custom peptides and amino acids direct from the manufacturer since 1998. ISO 9001 / cGMP. Batch COA every order.

glbiochem.net
c/glp1eu rules
  1. Tag your country in the title. Bare "EU" questions get a template reply.
  2. Pricing posts need the date and the currency.
  3. EMA and national agency claims need a citation.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.